Huishou Q. Fan

Qingdao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Real-world efficacy and safety of the carfilzomib-pomalidomide-dexamethasone regimen in patients with relapsed/refractory multiple myeloma: A multicenter retrospective study.

Real-world efficacy and safety of the carfilzomib-pomalidomide-dexamethasone regimen in patients with relapsed/refractory multiple myeloma: A multicenter retrospective study.

Journal: Therapeutic advances in hematology

Published: July 08, 2025

A Sole p.G391E Mutation in PML::RARA Identified in Relapsed Acute Promyelocytic Leukemia

A Sole p.G391E Mutation in PML::RARA Identified in Relapsed Acute Promyelocytic Leukemia

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: July 09, 2024

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 21, 2024

MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities.

MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities.

Journal: Haematologica

Published: November 15, 2023

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 19, 2023

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 19, 2023

Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.

Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.

Journal: Therapeutic advances in medical oncology

Published: July 12, 2023

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.

Journal: American journal of hematology

Published: May 26, 2023

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.

Journal: Haematologica

Published: May 14, 2023

Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment.

Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment.

Journal: Cancer research communications

Published: April 26, 2023

Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.

Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.

Journal: Cancer

Published: April 21, 2023

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.

Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.

Journal: Cancer biology & medicine

Published: January 17, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026